A. le Maître

发表

Pharmacogenetic Analysis of BR.21, a Placebo-Controlled Randomized Phase III Clinical Trial of Erlotinib in Advanced Non-small Cell Lung Cancer

L. Seymour, M. Tsao, K. Ding, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Venous thromboembolism and nonsmall cell lung cancer

L. Seymour, K. Ding, F. Shepherd, 2009, Cancer.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

J. Pignon, J. Bourhis, E. Maillard, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hyperfractionated or accelerated radiotherapy for head and neck cancer.

K. Ang, J. Horiot, J. Pignon, 2010, The Cochrane database of systematic reviews.

Individual patients' data meta-analyses in head and neck cancer

J. Pignon, J. Bourhis, A. le Maître, 2007, Current opinion in oncology.

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

M. Ellis, G. Sledge, A. L. Maître, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyperfractionated or accelerated radiotherapy for head and neck cancer.

K. Ang, J. Horiot, J. Pignon, 2010 .

Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group

L. Seymour, K. Ding, F. Shepherd, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effects of adjuvant exemestane versus anastrozole on bone mineral density: Two-year results of the NCIC CTG MA.27 bone companion study.

J. Ingle, P. Goss, A. Cheung, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A meta-analysis of individual patient data from randomized trials assessing chemotherapy with and without estramustine in patients with castration-refractory prostate cancer.

J. Pignon, A. L. Maître, S. Michiels, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21.

L. Seymour, M. Tsao, K. Ding, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial.

A. Bezjak, L. Seymour, K. Ding, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.

J. Pignon, S. Michiels, C. Logothetis, 2007, The Lancet. Oncology.

Relationship of treatment-emergent symptoms and recurrence-free survival in the NCIC CTG MA.27 adjuvant aromatase inhibitor trial.

M. Ellis, G. Sledge, J. Ingle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

J. Pignon, J. Bourhis, A. le Maître, 2007, International journal of radiation oncology, biology, physics.

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

Tomasz Burzykowski, Marc Buyse, Stefan Michiels, 2009, The Lancet. Oncology.

The Influence of Sex on Efficacy, Adverse Events, Quality of Life, and Delivery of Treatment in National Cancer Institute of Canada Clinical Trials Group Non-small Cell Lung Cancer Chemotherapy Trials

A. Bezjak, L. Seymour, K. Ding, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Presentation of nonfinal results of randomized controlled trials at major oncology meetings.

D. Cescon, K. Ding, C. Booth, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21.

L. Seymour, M. Tsao, K. Ding, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

M. Buyse, J. Pignon, T. Pajak, 2009, The Lancet. Oncology.

An evaluation of the possible interaction of gastric acid suppressive medication and the EGFR tyrosine kinase inhibitor erlotinib.

L. Seymour, F. Shepherd, D. Tu, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.